GTR 80575106

Tenders Are Invited For Pharmaceutical Products – Anti-Tumor Agents

ICB — International Competitive Bid Closed Western Europe
Tender Information
GTR Reference
80575106
Tendering Authority
Subscribe to view
Tender No
297056-2024
Financer Name
Self-Funded
Work Title
Tenders Are Invited For Pharmaceutical Products – Anti-Tumor Agents
Bid Type
ICB — International Competitive Bid
Country
Subscribe to view
Geographical Region
Western Europe
Political Region
European Union
Last Date of Bid Submission
06-06-2024 Closed
Work Detail
Pharmaceutical Products – Anti-Tumor Agents. Aflibercept Iv,Atezolizumab Iv,Avelumab Iv,Azacitidine Iv,Bcg I.Vesic.,Bendamustine Iv,Bevacizumab Iv,Bleomycine Iv,Bortezomib Iv/Sc,Brentuximab Vedotine Iv,Cabazitaxel Iv,Carboplatine Iv,Carfilzomib Iv,Cemiplimab Iv,Cetuximab Iv,Cisplatin Iv,Cladribine Iv,Cyclofosfamide Iv,Cytarabine Iv/Sc/I.Thec,Cytarabine Iv Lot 2,Dacarbazine Iv,Daratumumab I.V.,Docetaxel Iv,Doxorubicin In Pegylated Liposomes Iv,Doxorubicine In Liposomen Iv,Doxorubicine Iv,Durvalumab Iv,Enfortumab Iv,Epirubicine Iv,Eribulin Iv,Etoposide Iv,Fludarabine Iv,Flurouracil Iv,Fulvestrant Iv,Gemcitabine Iv,Ifosfamide Iv,Ipilimumab Iv,Irinotecan In Pegylated Liposomes Iv,Irinotecan Iv,Mesna Iv,Methotrexaat Iv/Im.I.Thec. Lot 1,Methotrexaat Iv/Im/I.Thec. Lot 2,Methotrexaat Iv/Im/I.Thec./I.Art. Lot 3,Methotrexaat Iv/Im/I.Thec./I.Art. Lot 4,Mitomycine Iv/I.Vesic,Mogamulizumab Iv,Nivolumab Iv,Obinutuzumab Iv,Oxaliplatine Iv,Paclitaxel Iv,Paclitaxel Iv Nano,Panitumumab Iv,Pembrolizumab Iv,Pemetrexed Iv,Pertuzumab Iv,Raltitrexed Iv,Ramucirumab Iv,Rituximab Iv,Rituximab Iv/Sc,Sacituzumab Iv,Tafacitamab Iv,Teclistamab Iv,Topotecan Iv,Trabectedine Iv,Trastuzumab I.V.,Trastuzumab Sc,Trastuzumab Deruxtecan Iv,Trastuzumab Emtansine Iv,Vinblastine Iv,Vincrisin Iv,Vinorelbine Iv,Abemaciclib Oral,Abiraterone Oral,Acalabrutinib Oral,Alectinib Oral,Anagrelide Oral,Anastrozole Oral,Apalutamide Oral,Axitinib Orally,Bexarotene Orally,Bicalutamide Oral,Bosutinib Oral,Cabozantinib Orally,Capecitabine Oral,Chlorambucil Oral,Cyclophosphamide Orally,Dabrafenib Oral,Darolutamide Oral,Dasatinib Orally,Enzalutamide Orally,Everolimus Oral,Fedratinib Oral,Hydroxycarbamide Oral,Ibrutinib Oral,Imatinib Orally,Ixazomib Oral,Oral Lenalidomide,Lenvatinib Orally,Lomustine Oral,Lorlatinib Orally,Melphalan Orally,Methotrexate Oral,Nilotinib Orally,Nintedanib Oral,Niraparib Oral,Olaparib Oral,Osimertinib Oral,Palbociclib Oral,Pazopanib Oral,Pomalidomide Oral,Ponatinib Orally,Regorafinib Oral,Ribociclib Oral,Ruxolitinib Oral,Sorafenib Oral,Sunitinib Oral,Tamoxifen Oral,Temozolomide Oral,Thalidomide Oral,Trametinib Oral,Tretinoin Oral,Trifluridine + Tipiracil Oral,Tucatinib Oral,Venetoclax Oral,Vismodegib Oral,Zanubrutinib Oral
Key Value
Tender Value
Ref. Document
Tender Documents
Global Tender Document
e86335d7-d00e-4f1d-b608-826636183bac.html
Attachments
Additional Details Available on Click
  • Tendering Authority
  • Publication Document (Tender Document / Tender Notice)
Disclaimer

We take all possible care for accurate & authentic tender information. However, users are requested to refer to the original Tender Notice / Tender Document published by the Tender Issuing Agency before taking any decision regarding this tender.

Tell us about your Product / Services,

We will Find Tenders for you